We are live on
!
Find out more
Simplify Asset Management Portfolio holdings
AUM
$7.19B
Turnover
25.77%
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter
Est. Return
+0.82%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$696M
(+13%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
18.61%
Top 10 Holdings %
Top 10 Hldgs %
92.45%
Holding
166
New
37
Increased
75
Reduced
18
Closed
24
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
0.9
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Government Money Market ETF
SBIL
|
+$1.05B |
| 2 |
UnitedHealth
UNH
|
+$23.9M |
| 3 |
Eli Lilly
LLY
|
+$17.5M |
| 4 |
Amgen
AMGN
|
+$16.6M |
| 5 |
Align Technology
ALGN
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Aggregate Bond ETF
AGGH
|
+$38.7M |
| 2 |
Simplify Multi-QIS Alternative ETF
QIS
|
+$15M |
| 3 |
Simplify Currency Strategy ETF
FOXY
|
+$9.3M |
| 4 |
Simplify Target 15 Distribution ETF
XV
|
+$9.29M |
| 5 |
Simplify Barrier Income ETF
SBAR
|
+$7.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.9% |
| 2 | Healthcare | 5.76% |
| 3 | Energy | 0.41% |
| 4 | Industrials | 0.31% |
| 5 | Technology | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$129B
| $7.93M | 0.13% |
17,492
+16,267
| +1,328% | +$7.01M |
2024 Q4
4 quarters
|
|
27
10x Genomics
TXG
$9.43B
| $7.93M | 0.13% |
+485,977
| New | +$7.34M |
2025 Q4
0 quarters
|
|
28
EyePoint Inc
EYPT
$271M
| $6.86M | 0.11% |
375,264
+284,824
| +315% | +$4.04M |
2025 Q1
3 quarters
|
|
29
AstraZeneca
AZN
$259B
| $6.53M | 0.11% |
35,490
+17,018
| +92% | +$2.98M |
2025 Q1
3 quarters
|
|
30
Insmed
INSM
$21.7B
| $6.42M | 0.1% |
36,890
+17,226
| +88% | +$3.14M |
2024 Q4
4 quarters
|
|
31
Achieve Life Sciences
ACHV
$719M
| $5.89M | 0.1% |
1,184,512
| – | – |
2024 Q1
7 quarters
|
|
32
CVS Health
CVS
$118B
| $5.88M | 0.1% |
74,124
-10,802
| -13% | -$852K |
2024 Q4
4 quarters
|
|
33
Tesla
TSLA
$1.43T
| $5.78M | 0.09% |
12,843
-11,517
| -47% | -$5.11M |
2020 Q4
20 quarters
|
|
34
AbbVie
ABBV
$501B
| $5.43M | 0.09% |
23,777
-13,106
| -36% | -$2.99M |
2025 Q1
3 quarters
|
|
35
Phathom Pharmaceuticals
PHAT
$607M
| $5.34M | 0.09% |
321,935
| – | – |
2023 Q1
11 quarters
|
|
36
Establishment Labs
ESTA
$1.83B
| $5.31M | 0.09% |
72,894
+34,946
| +92% | +$2.11M |
2025 Q3
1 quarter
|
|
37
Alignment Healthcare
ALHC
$1.69B
| $5.19M | 0.08% |
262,880
+125,946
| +92% | +$2.26M |
2024 Q4
4 quarters
|
|
38
Penumbra
PEN
$12.7B
| $4.92M | 0.08% |
15,827
+7,485
| +90% | +$2.07M |
2025 Q3
1 quarter
|
|
39
PUT
Invesco QQQ Trust
QQQ
$487B
| $4.9M | 0.08% |
+8,000
| New | +$4.91M |
2025 Q4
0 quarters
|
|
40
VanEck Bitcoin Trust
HODL
$1.37B
| $4.77M | 0.08% |
192,930
-42,062
| -18% | -$1.19M |
2025 Q1
3 quarters
|
|
41
Gilead Sciences
GILD
$195B
| $4.6M | 0.08% |
37,479
-22,707
| -38% | -$2.76M |
2024 Q3
5 quarters
|
|
42
Johnson & Johnson
JNJ
$610B
| $4.54M | 0.07% |
21,960
+10,558
| +93% | +$2.09M |
2021 Q4
16 quarters
|
|
43
GE HealthCare
GEHC
$31.8B
| $4.43M | 0.07% |
54,028
+25,844
| +92% | +$2.01M |
2025 Q2
2 quarters
|
|
44
Mineralys Therapeutics
MLYS
$1.91B
| $4.14M | 0.07% |
114,182
-104,544
| -48% | -$4.19M |
2025 Q3
1 quarter
|
|
45
IQVIA
IQV
$44.6B
| $3.93M | 0.06% |
17,418
+8,374
| +93% | +$1.82M |
2025 Q2
2 quarters
|
|
46
Viridian Therapeutics
VRDN
$2.22B
| $3.22M | 0.05% |
103,531
+53,531
| +107% | +$1.47M |
2025 Q3
1 quarter
|
|
47
Simplify Ancorato Target 25 Distribution ETF
XXV
$49.5M
| $3.18M | 0.05% |
+125,000
| New | +$3.2M |
2025 Q4
0 quarters
|
|
48
Milestone Pharmaceuticals
MIST
$98.9M
| $3.04M | 0.05% |
1,506,405
-1,326,569
| -47% | -$2.86M |
2025 Q1
3 quarters
|
|
49
Guardant Health
GH
$22.3B
| $3.02M | 0.05% |
29,581
-1,519
| -5% | -$136K |
2025 Q2
2 quarters
|
|
50
Oscar Health
OSCR
$10.3B
| $2.95M | 0.05% |
+205,131
| New | +$3.55M |
2025 Q4
0 quarters
|
|
Similar funds
SAM
Simplify Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Simplify Asset Management held 166 positions worth $6.13B, up 13% from $5.43B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $1.14B of net new capital in Q4 2025, opening 37 new positions and adding to 75 existing holdings. Its largest new stake was Amgen: 52,350 shares worth $17.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Simplify Aggregate Bond ETF, an estimated $38.7M trimmed.
- Simplify Asset Management's largest Q4 2025 buy was Amgen: 52,350 shares worth $17.1M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q4 2025, an estimated $1.05B increase.
- Simplify Asset Management's biggest Q4 2025 reduction was Simplify Aggregate Bond ETF, cutting an estimated $38.7M.
- Simplify Asset Management fully exited Simplify Currency Strategy ETF in Q4 2025, selling an estimated $9.3M.
- Simplify Asset Management's ten largest holdings make up 92% of its $6.13B portfolio in Q4 2025.
- Simplify Asset Management opened 37 new positions and closed 24 in Q4 2025.
- Simplify Asset Management's portfolio value rose 13% quarter-over-quarter to $6.13B.
Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.